India, China set to dominate global generic market

Tuesday, 30 November 2010, 18:10 Hrs
Printer Print Email Email
Mumbai: India and China are all set to dominate the global generic (off-patent drugs) market as low manufacturing and R&D cost would prompt key pharma players to set up their base here, a report said.

According to 'Health Paper', a report on the global generic market by industry body FICCI, low manufacturing and R&D cost in India and China as compared to other European markets will force most of the pharma players to shift their focus to these two countries.

"...total manufacturing cost per unit in India is half compared to that of any European facility. Similarly, the R&D cost is substantially lower in India and China. This will force key pharma players to set up units here," it said.
Source: PTI
SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..